+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 169 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are evaluating two different techniques of genicular nerve block to manage pain and improve quality of life in people with Knee Osteoarthritis KOA, a condition where the knee joint cartilage and bone break down. The study compares the commonly used 3-needle protocol targeting three specific genicular nerves with a newer 5-needle approach designed to block additional sensory nerve branches for potentially better pain relief. Participants will be randomly assigned to receive either the 3-needle or the 5-needle genicular nerve block. These nerve blocks are injections aimed at reducing knee pain by targeting nerves around the knee joint. Both groups will be monitored to assess their pain levels, quality of life, opioid medication use, and patient satisfaction over a period of six months after treatment. During the study, participants will undergo evaluations to measure changes in their knee pain and quality of life at six months post-treatment. Researchers will also track the use of opioid pain medications and overall satisfaction with the procedures. The study is double-blinded, meaning neither participants nor researchers know which treatment is given to ensure unbiased results. The entire participation lasts through six months of follow-up after the nerve block treatment.

Age: 18Years +All GendersPhase Not Applicable
1 location
E

Actively Recruiting

Healthy Volunteer

This clinical trial focuses on evaluating how different 3D printing angles and layer thicknesses affect the fit, accuracy, and patient satisfaction of maxillary complete dentures in patients who have lost all their upper teeth. The study involves adults aged 50 to 70 with complete edentulism who require new maxillary and mandibular dentures. Researchers aim to identify the best 3D printing settings for making these dentures by comparing three build orientations 0, 45, and 90. Participants will receive two maxillary dentures made using the same printing orientation but with two different layer thicknesses 50 micrometers and 100 micrometers in a crossover design. Each denture will be worn for three months before switching to the other. The study groups are based on the printing angle used 0, 45, or 90. The accuracy of the dentures is measured by scanning and comparing the printed dentures to the original digital designs. During the study, participants will be assessed on how true to the design the dentures are, how much the dentures change dimensionally over three months, and their satisfaction based on comfort, speech, chewing efficiency, hygiene, and appearance. Satisfaction is measured using a Visual Analogue Scale shortly after insertion and again after three months of use. The study will last about six months per participant, covering both denture wear periods.

Age: 50Years - 70YearsAll GendersPhase Not Applicable
1 location
C

Actively Recruiting

Researchers are evaluating the effectiveness of 3D-printed palatal cribs compared to conventional soldered palatal cribs in treating the tongue thrusting habit in children aged 7 to 10 years. This randomized controlled trial aims to compare clinical outcomes in pediatric patients with this oral habit and an Angle Class I molar relationship. The study focuses on how these two types of appliances manage tongue thrusting and their impact on dental and oral health. Participants are randomly assigned to one of two groups one receiving a custom 3D-printed palatal crib made from cobalt-chromium alloy using selective laser melting based on digital intraoral scans, and the other treated with a conventional stainless steel soldered palatal crib made with traditional methods. The appliances are cemented to the maxillary first permanent molars using specific bonding procedures. Follow-up assessments occur over a 6-month period to evaluate treatment effects and device performance. During the study, children will undergo dental cast analyses at the start and after 6 months to measure changes in dental dimensions such as overjet, overbite, and arch widths. Researchers will also monitor the appliances survival and structural integrity at multiple time points up to 6 months. Oral health is assessed through gingival and plaque indices, and patient comfort and acceptance are recorded throughout. The study tracks these outcomes to understand the clinical effectiveness and patient experience with each type of palatal crib.

Age: 7Years - 10YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are investigating the safety, compliance, and effectiveness of different bowel preparation methods before colonoscopy. This randomized controlled trial compares three regimens a 4-liter split-dose polyethylene glycol combined with bisacodyl and docusate sodium, a 2-liter split-dose polyethylene glycol plus oral simethicone, and a conventional 2-liter split-dose polyethylene glycol alone. The study aims to assess how well these methods prepare the bowel and their tolerability for patients undergoing colonoscopy. Participants will be randomly assigned to one of three groups. One group receives four sachets of polyethylene glycol mixed in 4 liters of water over 8 hours starting at 9 a.m., along with bisacodyl and docusate sodium tablets. The second group receives two sachets of polyethylene glycol mixed in 2 liters of water over 4 hours from 9 a.m. plus oral simethicone tablets. The third group receives two sachets of polyethylene glycol in 2 liters of water over 4 hours starting at 9 a.m. without simethicone. Colonoscopy is performed 24 hours after starting the preparation. During the study, participants will undergo medical history taking, clinical exams, laboratory tests, and colonoscopy. Researchers will evaluate the quality of bowel preparation using the Aronchick scale, monitor adverse events, and collect patient feedback on ease of use, tolerability, and willingness to repeat the same regimen in the future. The primary outcome is completing a full colonoscopy successfully, with safety and tolerability tracked throughout the study period, which lasts about one year.

Age: 18Years - 70YearsAll GendersPhase Not Applicable
1 location
O

Actively Recruiting

Diffuse large B-cell lymphoma DLBCL is the most common and aggressive subtype of non-Hodgkin lymphoma NHL, affecting many patients with rapid tumor growth and symptoms depending on tumor location. This observational study aims to understand the clinical characteristics, treatment patterns, and access to new therapies for patients with DLBCL in the Middle East and Africa region, including both newly diagnosed and relapsed or refractory cases. Participants are grouped into two cohorts those who are newly diagnosed and eligible for treatment, and those who have relapsed or are refractory after at least one prior therapy. The study does not involve experimental treatments but collects information on how patients are treated in real-world settings and explores access to innovative therapies. During the study, patient demographics, disease characteristics, risk profiles, and treatment patterns are documented over 22 months. Researchers will gather data through reviews of medical records and clinical information without administering treatments. The primary goal is to describe first-line and subsequent treatment approaches and to understand patient access to novel therapies for DLBCL.

All AgesAll Genders
21 locations
C

Actively Recruiting

Healthy Volunteer

This research aims to compare the safety and effectiveness of three different endoscopic techniques for removing large prostate tissue in men with benign prostatic hyperplasia BPH who experience severe urinary symptoms. The study focuses on men with prostate sizes over 100 mL who have not responded to medical treatments and have significant symptoms measured by the International Prostate Symptom Score IPSS and urinary flow rates. The trial is a prospective randomized controlled study conducted at Tanta University Hospital, evaluating three surgical methods used to treat large prostates causing lower urinary tract symptoms. Participants will be randomly assigned to one of three groups, each undergoing a different prostate enucleation procedure Thulium Fiber Laser Enucleation ThuFLEP using a 60W thulium fiber laser, Holmium Laser Enucleation HoLEP using a 150W holmium YAG laser, or Bipolar Transurethral Enucleation B-TUEP using bipolar electrical energy. All procedures are performed transurethrally and involve removing the prostate tissue with a morcellator. Each group will have 30 patients, and the study will run from October 2025 to October 2027. Participants will undergo thorough preoperative assessments including symptom scores, urinary flow tests, ultrasounds, blood tests, and prostate-specific antigen measurements. After surgery, follow-ups at 1, 3, and 6 months will evaluate symptom relief, quality of life, urinary flow rate, residual urine volume, and erectile function. Researchers will also track operative times, blood loss, catheter duration, hospital stay, and complications categorized by the Clavien-Dindo system. The study measures both patient outcomes and surgical efficiency over six months post-operation.

All AgesMALEPhase Not Applicable
1 location
E

Actively Recruiting

Researchers are evaluating the effect of alveolar bone decortication combined with Concentrated Growth Factor CGF injection on speeding up tooth movement, specifically maxillary canine retraction. This randomized clinical trial aims to assess whether adding this procedure can accelerate orthodontic treatment in patients aged 16 to 22 years who require canine retraction after premolar extraction. Participants will receive two different treatments on each side of their maxillary arch. One side will undergo alveolar decortication, a surgical procedure involving creating multiple perforations in the cortical bone near the maxillary canine followed by a submucosal injection of 70 units of CGF. The other side will receive the standard orthodontic treatment without any additional intervention. The treatment duration and follow-up will last for up to 4 months. During the study, participants will be evaluated for the rate of canine tooth movement over 4 months. Researchers will monitor the acceleration of tooth movement by comparing the treated side to the control side within the same participant. Safety and oral hygiene will be assessed throughout the trial, and participants will have regular follow-ups as part of the orthodontic treatment plan.

Age: 16Years - 22YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are comparing the effectiveness and safety of three add-on drugsempagliflozin, acetazolamide, and metolazonewhen given with loop diuretics to patients hospitalized with acute decompensated heart failure. This phase 2 clinical trial aims to understand which of these treatments best supports fluid removal and heart failure management in this patient group. The study includes three groups of 22 patients each. One group receives 10 mg of empagliflozin, another 500 mg of acetazolamide, and the third 5 mg of metolazone. Each drug is given orally alongside the first dose of loop diuretics daily for three days. The trial does not use placebos and participants are randomly assigned to one of the three treatment groups. Participants will be closely monitored during the three-day treatment period with measurements such as total urine output and changes in specific blood and urine biomarkers related to heart failure. Researchers will also track 30-day mortality rates and assess treatment effectiveness using the ADVOR Score. This monitoring helps evaluate the safety and impact of these add-on therapies over the short term and up to 30 days after treatment begins.

Age: 18Years +All GendersPhase 2
1 location
S

Actively Recruiting

This research aims to evaluate the effect of adding calcitonin to bupivacaine during an ultrasound-guided transversalis fascia plane block for women undergoing cesarean section. The study is a prospective randomized trial designed to compare pain relief methods in this surgical setting.

All AgesFEMALEPhase Not Applicable
1 location
A

Actively Recruiting

This research aims to evaluate whether guiding pressure support ventilation using Airway Occlusion Pressure P0.1 is better than conventional management for patients in the weaning window from mechanical ventilation. The study focuses on critically ill adults with acute respiratory failure who are transitioning from assisted ventilation toward spontaneous breathing. It highlights the importance of optimizing ventilator weaning to reduce risks like lung injury and diaphragm dysfunction. Participants will be randomly assigned to one of two groups. One group will receive conventional pressure support ventilation based on clinical assessment, while the other group will have pressure support ventilation guided by P0.1 measurements, which assess the patients respiratory drive more directly. The study monitors treatment effects over time, focusing on ventilator-free days and other important clinical outcomes. During the trial, participants will be closely monitored for respiratory status, sedation levels, and hemodynamic stability. Assessments include measuring ventilator-free days by day 28, duration of mechanical ventilation until successful extubation, length of ICU stay, patient-ventilator synchrony, sedation drug requirements, and weaning success. The study involves regular clinical evaluations to track these outcomes and ensure participant safety throughout the treatment period.

Age: 21Years +All GendersPhase Not Applicable
1 location

1-10 of 169

1